Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    granules-india-limited-m-2025-07-07

    Virtual Booth

    Contact Supplier

    Allsino Pharma excels in R&D & manufacturing of RSMs, GMP intermediates, & APIs; ISO-certified, GMP-compliant, accredited by NMPA.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Aceclidine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lenz Therapeutics & Lab Théa Ink Exclusive Deal for Lnz100
    Lenz Therapeutics & Lab Théa Ink Exclusive Deal for Lnz100

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3110985/0/en/LENZ-Therapeutics-and-Laboratoires-Th%C3%A9a-Announce-Exclusive-License-and-Commercialization-Agreement-for-LNZ100-in-Canada.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share
    Lenz Therapeutics to Present at Upcoming Investor Conferences
    Lenz Therapeutics to Present at Upcoming Investor Conferences

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088557/0/en/LENZ-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    LENZ Announces Topline Data from PhII Trial of LNZ100 & LNZ101
    LENZ Announces Topline Data from PhII Trial of LNZ100 & LNZ101

    18 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221018005258/en

    BUSINESSWIRE
    18 Oct 2022
    Share Share